Selected article for: "acute lung injury and lung barrier"
Author: Lin, Frank Cheau-Feng; Lee, Shiuan-Shinn; Li, Yi-Ching; Ho, Yung-Chuan; Chen, Wen-Ying; Chen, Chun-Jung; Lee, Min-Wei; Yeh, Kun-Lin; Tsai, Stella Chin-Shaw; Kuan, Yu-Hsiang
Title: Protective Effects of Kirenol against Lipopolysaccharide-Induced Acute Lung Injury through the Modulation of the Proinflammatory NFκB Pathway and the AMPK2-/Nrf2-Mediated HO-1/AOE Pathway
  • Cord-id: ekngrhy3
  • Document date: 2021_1_31
    • ID: ekngrhy3
    Snippet: Acute lung injury (ALI) is an acute and life-threatening inflammatory disease of the lung parenchyma that is associated with high mortality worldwide. No therapeutic strategies have been developed for the mitigation of the proinflammatory response that characterizes ALI. Kirenol has anti-inflammatory, antiarthritic, and immunoregulatory effects. In the present study, we investigated the protective effects of kirenol against lipopolysaccharides (LPS)-induced ALI in mice. Kirenol reduced the LPS-i
    Document: Acute lung injury (ALI) is an acute and life-threatening inflammatory disease of the lung parenchyma that is associated with high mortality worldwide. No therapeutic strategies have been developed for the mitigation of the proinflammatory response that characterizes ALI. Kirenol has anti-inflammatory, antiarthritic, and immunoregulatory effects. In the present study, we investigated the protective effects of kirenol against lipopolysaccharides (LPS)-induced ALI in mice. Kirenol reduced the LPS-induced histopathology changes involving edema and thickening of the interstitial or alveolar walls, infiltration of leukocytes, formation of hyaline membrane. Pretreatment with kirenol reduced leukocytes infiltration in bronchoalveolar lavage fluid (BALF), the alveolar-capillary barrier disruption and lipid peroxidation in lung tissues induced by LPS. Kirenol significantly inhibited the secretion of cytokines, IL-1β, IL6, and TNFα, into the BALF of the mice with LPS-induced ALI through NFκB activation. Moreover, kirenol attenuated the downregulation of the antioxidant enzymes, superoxide dismutase, glutathione peroxidase, and catalase that was induced by LPS. HO-1 expression and the phosphorylation of Nrf2 and AMPK2 were also induced by kirenol. The results indicate that kirenol can be developed as a treatment strategy for ALI, and its effects are induced through the inhibition of the NF-κB proinflammatory pathway and promotion of AMPK2/Nrf2-mediated HO-1 and antioxidant enzymes (AOE) activation.

    Search related documents:
    Co phrase search for related documents
    • accumulation leukocyte infiltration and acute inflammation: 1
    • accumulation leukocyte infiltration and acute respiratory syndrome: 1
    • activate protein and acute inflammation: 1
    • activate protein and acute respiratory distress syndrome: 1
    • activate protein and acute respiratory distress syndrome respiratory failure: 1
    • activate protein and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • activate protein and adaptive response: 1, 2
    • active component and acute ali lung injury: 1
    • active component and acute inflammation: 1
    • active component and acute respiratory distress syndrome: 1
    • active component and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ali lung injury and adaptive response: 1, 2, 3
    • acute ali lung injury and lps administration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute ali lung injury and lps challenge: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute ali lung injury and lps induce: 1, 2, 3, 4, 5, 6
    • acute ali respiratory distress syndrome and adaptive response: 1, 2, 3
    • acute ali respiratory distress syndrome and lps administration: 1, 2, 3, 4
    • acute ali respiratory distress syndrome and lps induce: 1, 2
    • acute inflammation and lps challenge: 1, 2